Minghua Wang
31Patents
9h-index
20Co-inventors
67Inventor score
Filing activity: Dec 29, 2015 → Sep 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9840491B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 21 | Active |
| US9902728B2 | Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US9932351B2 | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US9938300B2 | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 20 | Active |
| US10000495B2 | Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors | Human Necessities | 20 | Active |
| US10377773B2 | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 16 | Active |
| US10377760B2 | Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 15 | Active |
| US10377767B2 | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 15 | Active |
| US10351571B2 | Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors | Human Necessities | 15 | Active |
| US10519129B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10519130B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10519128B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10519127B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10508098B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10513507B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10513508B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 8 | Active |
| US10934299B2 | Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10836741B2 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10981915B2 | Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors | Human Necessities | 3 | Active |
| US10906916B2 | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US10189841B2 | Purinones as ubiquitin-specific protease 1 inhibitors | Human Necessities | 3 | Active |
| US10927130B2 | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10399980B2 | Purinones as ubiquitin-specific protease 1 inhibitors | Human Necessities | 2 | Active |
| US11161848B2 | Purinones as ubiquitin-specific protease 1 inhibitors | Human Necessities | 1 | Active |
| US11001592B2 | DNA polymerase IIIC inhibitors and use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.